Table 3.
CLL-IPI risk group | MBL | |||||
---|---|---|---|---|---|---|
Time to first therapy | Overall survival | |||||
HR | 95% CI | P | HR | 95% CI | P | |
Intermediate vs low | 2.7 | 1.6-4.5 | .0002 | 1.9 | 1.1-3.1 | .01 |
High vs low | 6.2 | 3.1-12.5 | <.0001 | 2.6 | 1.4-5.1 | .003 |
Very high vs low | Not estimable | — | — | 5.3 | 1.3-22.0 | .02 |
CLL-IPI risk group | CLL | |||||
Time to first therapy | Overall survival | |||||
HR | 95% CI | P | HR | 95% CI | P | |
Intermediate vs low | 2.9 | 2.1-4.0 | <.0001 | 2.0 | 1.4-3.0 | .0005 |
High vs low | 6.1 | 3.7-9.5 | <.0001 | 4.2 | 2.5-7.2 | <.0001 |
Very high vs low | 5.4 | 1.8-15.0 | .002 | 12.2 | 5.9-25.1 | <.001 |
Values in bold indicate P < .05.